Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
Low circulating serum levels of second mitochondria-derived activator of caspase (Smac/DIABLO) in patients with bladder cancer.
Mizutani Y, Katsuoka Y, Bonavida B.
Int J Oncol. 2012 Apr;40(4):1246-50. doi: 10.3892/ijo.2012.1324. Epub 2012 Jan 3.
Related citations
Novel oncogenic function of mesoderm development candidate 1 and its regulation by MiR-574-3p in bladder cancer cell lines.
Tatarano S, Chiyomaru T, Kawakami K, Enokida H, Yoshino H, Hidaka H, Nohata N, Yamasaki T, Gotanda T, Tachiwada T, Seki N, Nakagawa M.
Int J Oncol. 2012 Apr;40(4):951-9. doi: 10.3892/ijo.2011.1294. Epub 2011 Dec 13.
Identification of a methylation hotspot in the death receptor Fas/CD95 in bladder cancer.
Watson CJ, O'Kane H, Maxwell P, Sharaf O, Petak I, Hyland PL, O'Rouke D, McKnight J, Canning P, Williamson K.
Int J Oncol. 2012 Mar;40(3):645-54. doi: 10.3892/ijo.2011.1250. Epub 2011 Nov 4.
A novel synthetic 2-(3-methoxyphenyl)-6,7-methylenedioxoquinolin-4-one arrests the G2/M phase arrest via Cdc25c and induces apoptosis through caspase- and mitochondria-dependent pathways in TSGH8301 human bladder cancer cells.
Hsu SC, Yu CC, Yang JS, Lai KC, Wu SH, Lin JJ, Kuo JH, Yang ST, Huang CC, Kuo SC, Chung JG.
Int J Oncol. 2012 Mar;40(3):731-8. doi: 10.3892/ijo.2011.1241. Epub 2011 Oct 21.
The androgen receptor and stem cell pathways in prostate and bladder cancers (review).
Marcinkiewicz K, Scotland KB, Boorjian SA, Nilsson EM, Persson JL, Abrahamsson PA, Allegrucci C, Hughes IA, Gudas LJ, Mongan NP.
Int J Oncol. 2012 Jan;40(1):5-12. doi: 10.3892/ijo.2011.1212. Epub 2011 Sep 28. Review.
Urothelial cancer cell response to combination therapy of gemcitabine and TRAIL.
Moibi JA, Mak AL, Sun B, Moore RB.
Int J Oncol. 2011 Jul;39(1):61-71. doi: 10.3892/ijo.2011.1023. Epub 2011 Apr 29.
Opioids increase bladder cancer cell migration via bradykinin B2 receptors.
Vassou D, Notas G, Hatzoglou A, Castanas E, Kampa M.
Int J Oncol. 2011 Sep;39(3):697-707. doi: 10.3892/ijo.2011.1063. Epub 2011 Jun 3.
Aberrant DNA methylation of T-cell leukemia, homeobox 3 modulates cisplatin sensitivity in bladder cancer.
Tada Y, Yokomizo A, Shiota M, Tsunoda T, Plass C, Naito S.
Int J Oncol. 2011 Sep;39(3):727-33. doi: 10.3892/ijo.2011.1049. Epub 2011 May 23.
miR-218 on the genomic loss region of chromosome 4p15.31 functions as a tumor suppressor in bladder cancer.
Tatarano S, Chiyomaru T, Kawakami K, Enokida H, Yoshino H, Hidaka H, Yamasaki T, Kawahara K, Nishiyama K, Seki N, Nakagawa M.
Int J Oncol. 2011 Jul;39(1):13-21. doi: 10.3892/ijo.2011.1012. Epub 2011 Apr 20.
Opposite regulation of epithelial-to-mesenchymal transition and cell invasiveness by periostin between prostate and bladder cancer cells.
Kim CJ, Sakamoto K, Tambe Y, Inoue H.
Int J Oncol. 2011 Jun;38(6):1759-66. doi: 10.3892/ijo.2011.997. Epub 2011 Apr 5.
Chetomin induces degradation of XIAP and enhances TRAIL sensitivity in urogenital cancer cells.
Yano K, Horinaka M, Yoshida T, Yasuda T, Taniguchi H, Goda AE, Wakada M, Yoshikawa S, Nakamura T, Kawauchi A, Miki T, Sakai T.
Int J Oncol. 2011 Feb;38(2):365-74. doi: 10.3892/ijo.2010.874. Epub 2010 Dec 15.
Utility of the novel bladder preservation therapy, BOAI-CDDP-radiation (OMC-regimen), for elderly patients with invasive bladder cancer.
Azuma H, Inamoto T, Ibuki N, Ubai T, Kotake Y, Takahara K, Kiyama S, Nomi H, Uehara H, Komura K, Yamamoto K, Narumi Y, Katsuoka Y.
Int J Oncol. 2011 Jan;38(1):13-24.
CpG hypermethylation of cellular retinol-binding protein 1 contributes to cell proliferation and migration in bladder cancer.
Toki K, Enokida H, Kawakami K, Chiyomaru T, Tatarano S, Yoshino H, Uchida Y, Kawahara K, Nishiyama K, Seki N, Nakagawa M.
Int J Oncol. 2010 Dec;37(6):1379-88.
Cantharidin induces apoptosis in human bladder cancer TSGH 8301 cells through mitochondria-dependent signal pathways.
Kuo JH, Chu YL, Yang JS, Lin JP, Lai KC, Kuo HM, Hsia TC, Chung JG.
Int J Oncol. 2010 Nov;37(5):1243-50.
Novel bladder preservation therapy for locally invasive bladder cancer: combined therapy using balloon-occluded arterial infusion of anticancer agent and hemodialysis with concurrent radiation.
Int J Oncol. 2010 Oct;37(4):773-85.
Prognostic significance of second mitochondria-derived activator of caspase (Smac/DIABLO) expression in bladder cancer and target for therapy.
Int J Oncol. 2010 Aug;37(2):503-8.
BDNF mediated TrkB activation is a survival signal for transitional cell carcinoma cells.
Huang YT, Lai PC, Wu CC, Hsu SH, Cheng CC, Lan YF, Chiu TH.
Int J Oncol. 2010 Jun;36(6):1469-76.
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on